Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Mossop

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
BMC Medicine|October 2, 2025
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trialsHelen Mossop, Zoë Walmsley, Nina Wilson, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
The Lancet. Oncology|June 25, 2016
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialDavid Dearnaley, Isabel Syndikus, Helen Mossop, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMC Medicine|October 2, 2025
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trialsHelen Mossop, Zoë Walmsley, Nina Wilson, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
The Lancet. Oncology|June 25, 2016
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialDavid Dearnaley, Isabel Syndikus, Helen Mossop, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Pageof 3